Occurrence of CIP/CIM ‐ in screened population · critically ill patients
Early physical therapy probably leads to lower occurrence of CIP/CIM ‐ in screened population compared with control (moderate certainty).
1 finding from 1 review
Serious adverse events ‐ in total population randomised · critically ill patients
Early physical therapy showed no clear difference in serious adverse events ‐ in total population randomised compared with control (moderate certainty).
1 finding from 1 review
Occurrence of CIP/CIM ‐ in the total population randomised · critically ill patients
It is very uncertain whether electrical muscle stimulation changes occurrence of CIP/CIM ‐ in the total population randomised compared with control (very low certainty).
1 finding from 1 review
Occurrence of CIP/CIM ‐ in screened population · critically ill patients
It is very uncertain whether electrical muscle stimulation changes occurrence of CIP/CIM ‐ in screened population compared with control (very low certainty).
1 finding from 1 review
Occurrence of CIP/CIM ‐ in screened population · critically ill patients
Intensive insulin therapy probably leads to lower occurrence of CIP/CIM ‐ in screened population compared with conventional insulin therapy (moderate certainty).
1 finding from 1 review
Duration of mechanical ventilation · critically ill patients
1 finding from 1 review
Duration of ICU stay · critically ill patients
1 finding from 1 review
Death ‐ at 30 days after ICU admission, in total population randomised · critically ill patients
Intensive insulin therapy showed no clear difference in death ‐ at 30 days after ICU admission, in total population randomised compared with conventional insulin therapy (high certainty).
1 finding from 1 review
Death ‐ at 180 days after ICU admission, in total population randomised · critically ill patients
Intensive insulin therapy showed no clear difference in death ‐ at 180 days after ICU admission, in total population… compared with conventional insulin therapy (moderate certainty).
1 finding from 1 review
Serious adverse events, ‐ in total population randomised ‐ hypoglycaemia · critically ill patients
Intensive insulin therapy leads to higher serious adverse events, ‐ in total population randomised ‐… compared with conventional insulin therapy (high certainty).
1 finding from 1 review
Occurrence of CIP/CIM ‐ in the total population randomised · critically ill patients
Corticosteroids showed no clear difference in occurrence of CIP/CIM ‐ in total population randomised compared with placebo compared (low certainty).
1 finding from 1 review
Occurrence of CIP/CIM ‐ in screened population · critically ill patients
Corticosteroids showed no clear difference in occurrence of CIP/CIM ‐ in screened population compared with placebo compared (moderate certainty).
1 finding from 1 review
Intervention not reported
Presence of PHN 6 months after the onset of the acute herpetic rash2 Clinical diagnostic criteria for PHN in any intensity · people with acute herpes zoster1
1 finding from 1 review
Intervention not reported
Presence of PHN 4 months after the onset of the acute herpetic rash Clinical diagnostic criteria for PHN in any intensity · people with acute herpes zoster1
The intervention showed no clear difference in presence of PHN 4 months after the onset of the acute herpetic rash… (high certainty).
1 finding from 1 review
Intervention not reported
Adverse events Clinical manifestations · people with acute herpes zoster1
The intervention showed no clear difference in adverse events Clinical manifestations (high certainty).
1 finding from 1 review
Improved muscle function various methods1 · people with myasthenia gravis
1 finding from 1 review
no estimate extracted
10 participants
Very low
Adverse events · people with myasthenia gravis
1 finding from 1 review
Change in impairment 1 to 14 days after the start of treatment ‐ not reported · people with myasthenia gravis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Number of patients with ≥ 50% improvement of pain at 12 weeks or less Duloxetine 60 mg daily 11‐point Likert score · patients with painful neuropathy or chronic pain from diabetic peripheral neuropathy
The intervention probably leads to higher number of patients with ≥ 50% improvement of pain at 12 weeks or… (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events · patients with the chronic pain of fibromyalgia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found